NIH Office of Research Integrity

NIH Office of Research Integrity
Name	NIH Office of Research Integrity
Formed	1992
Headquarters	Bethesda, Maryland
Parent agency	United States Department of Health and Human Services
Chief1 name	Director

NIH Office of Research Integrity The NIH Office of Research Integrity oversees integrity in biomedical and behavioral research funded by federal grants, ensuring compliance with ethical and regulatory standards across institutions such as Harvard University, Johns Hopkins University, Stanford University, University of California, San Francisco and Massachusetts Institute of Technology. It interacts with agencies and entities including the National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention, National Science Foundation, and the Office of Inspector General to coordinate responses to allegations involving researchers affiliated with institutions like Columbia University, Yale University, University of Pennsylvania, Duke University, and University of Michigan. The office draws on precedent from investigations associated with figures and institutions such as Andrew Wakefield, Hwang Woo-suk, Haruko Obokata, Elizabeth Bik, and Fiona Godlee to shape policy and enforcement.

History

The office traces roots to efforts following high-profile controversies at institutions including University of Minnesota, Vanderbilt University, University of Texas Southwestern Medical Center, Cornell University, and University of California, Los Angeles that prompted congressional action in the wake of cases involving researchers like William Summerlin, John Darsee, Robert Gallo, Harold Varmus, and James Watson. Legislative and administrative milestones influencing the office include statutes and initiatives from the United States Congress, the Department of Health, Education, and Welfare, the Office of Research Integrity (1989), the Office of Inspector General (HHS), and guidance emerging after inquiries related to J. Craig Venter, Francis Collins, Collins' Human Genome Project, Kary Mullis, and debates at National Academies of Sciences, Engineering, and Medicine. The timeline reflects interactions with panels chaired by figures such as David Baltimore, Richard Nixon-era policies, and reviews influenced by reports from Institute of Medicine committees and investigations connected to Cold Spring Harbor Laboratory and Rockefeller University.

Mission and Responsibilities

The office’s mission aligns with obligations under laws and regulations shaped by the Public Health Service Act, the Health Research Extension Act, and directives from the Department of Health and Human Services. Responsibilities intersect with oversight bodies like the National Institutes of Health, Food and Drug Administration, Office of Management and Budget, Office of the Inspector General (HHS), and institutional review boards at Mayo Clinic, Cleveland Clinic, Mount Sinai Health System, Scripps Research, and Fred Hutchinson Cancer Research Center. The office issues guidance used by university compliance offices at Princeton University, Brown University, University of Chicago, Northwestern University, and University of Washington to address allegations similar to those in inquiries involving Marc Hauser, Woo Suk Hwang, Anil Potti, Paolo Macchiarini, and Scott Reuben.

Organizational Structure

The office reports within the United States Department of Health and Human Services framework, coordinating with the National Institutes of Health leadership, the Office for Human Research Protections, the Centers for Medicare & Medicaid Services, and the Office of the General Counsel (HHS). Internal divisions echo specialized roles found in entities like the Federal Bureau of Investigation, Office of Personnel Management, Government Accountability Office, National Academies, and academic compliance units at Emory University, University of Colorado, University of Pittsburgh, and Indiana University. Leadership transitions have involved collaborations with advisors and panels including representatives from Wellcome Trust, Howard Hughes Medical Institute, European Medicines Agency, World Health Organization, and professional societies such as the American Association for the Advancement of Science and the Association of American Medical Colleges.

Investigations and Procedures

Investigations follow procedures modeled after precedents from inquiries at National Institutes of Health, University of California, Harvard Medical School, and memoranda influenced by cases like Hwang Woo-suk, Andrew Wakefield, and Robert Gallo. Processes involve coordination with institutional officials at University of Iowa, Ohio State University, University of Florida, Penn State University, and University of North Carolina to manage allegations, gather evidence, apply standards found in the Federal Register, and determine findings of research misconduct such as falsification, fabrication, and plagiarism. Sanctions and corrective actions resemble outcomes imposed in cases adjudicated with involvement from Department of Justice, Office of Personnel Management, National Science Foundation, and disciplinary measures echoed in decisions involving entities like Royal Society-affiliated researchers and journals including Nature, Science (journal), The Lancet, New England Journal of Medicine, and JAMA.

Notable Cases and Outcomes

High-profile matters that shaped policy include investigations connected to scientists and institutions such as Hwang Woo-suk and Severance Hospital, Andrew Wakefield and Royal Free Hospital, Anil Potti and Duke University, Scott Reuben and Baystate Medical Center, Paolo Macchiarini and Karolinska Institute, and Haruko Obokata and RIKEN. Outcomes ranged from retractions in journals like Science (journal), Nature, Cell, The Lancet, and New England Journal of Medicine to administrative actions similar to those taken by Office of Inspector General (HHS), Department of Justice, and institutional boards at Yale New Haven Hospital, Brigham and Women's Hospital, Hospital of the University of Pennsylvania, and Johns Hopkins Hospital.

Policy and Guidance

The office issues policy documents and guidance articulating standards that parallel frameworks from the Public Health Service, Office of Management and Budget, International Committee of Medical Journal Editors, Committee on Publication Ethics, World Health Organization, European Commission, Wellcome Trust, and the National Academies of Sciences, Engineering, and Medicine. Guidance informs research integrity training programs at Harvard T.H. Chan School of Public Health, Johns Hopkins Bloomberg School of Public Health, Yale School of Medicine, Columbia University Vagelos College of Physicians and Surgeons, and UCSF School of Medicine, and shapes editorial policies at Nature Publishing Group, Elsevier, Wiley, Oxford University Press, and Springer Nature.

Criticism and Reforms

Critiques of the office’s practices evoke debates seen in reviews of investigations at RIKEN, Karolinska Institute, Duke University, Harvard University, and Rockefeller University and have prompted reform proposals advanced by organizations such as the National Academies, Wellcome Trust, Howard Hughes Medical Institute, European Research Council, and advocacy groups associated with Retraction Watch and scholars including Elizabeth Bik. Reforms discussed include enhancing transparency akin to models at Public Library of Science, improving whistleblower protections described in legislation debated in the United States Congress, strengthening coordination with the Department of Justice and Office of Inspector General (HHS), and adopting best practices from international bodies like the United Kingdom Research Integrity Office and the Australian Research Council.

Category:United States Department of Health and Human Services